A carregar...

Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs

Tumour cell heterogeneity is a major barrier for efficient design of targeted anti-cancer therapies. A diverse distribution of phenotypically distinct tumour-cell subpopulations prior to drug treatment predisposes to non-uniform responses, leading to the elimination of sensitive cancer cells whilst...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Comput Biol
Main Authors: Alarcón, Tomás, Sardanyés, Josep, Guillamon, Antoni, Menendez, Javier A.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248646/
https://ncbi.nlm.nih.gov/pubmed/34153035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pcbi.1008408
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!